According to a report published by Grand View Research, Inc.; the 3D cell culture market is expected to reach a valuation of around USD 1.69 billion by 2024.
Factors such as introduction of novel scaffolds and matrices and continuous developments in research and analytical processes can drive the market over the forecast period (2014 to 2025). In addition, development of 3D optimized assays, kits, and protocols coupled with advancements in assay techniques, is projected to accelerate market growth.
Full Research Report On 3D Cell Culture Market Analysis:
Increasing need to implement 3D cell culture systems in research for better representation of in vivo environment has lead the development of new materials and methods. This is likely to fuel the market growth in the coming years. These systems are more suitable for in vivo modeling as they provide similarity with morphology of organ or cells. These systems can be available in several options such as 3D bioreactor, scaffold-free, and scaffold-based systems. Introduction of scaffold-free technology for development of translational pathway for tissues is likely to support the market growth.
Worldwide cell culture market can be segmented on the basis of technology, application, end-use, component, and region.
Based on technology, the market can be bifurcated into scaffold based, scaffold free, and 3D bioreactors. The scaffold-free segment is expected to show rapid growth due to challenges associated with scaffolds-based systems. These challenges include interference of scaffolds with cell-to-cellular interactions and in assembly of cell produced extra cellular matrices (ECM).
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/healthcare
As per application, the market can be split into cancer, tissue engineering and immunohistochemistry, drug development, stem cell research, and others. The stem cell research segment is expected to show lucrative growth on account of employment of cellular models for differentiation and expansion of pluripotent stem cells-based on principle of scaffolding.
On the basis of end-use, the market can be categorized into biotechnology and pharmaceutical industries, research laboratories and institutes, hospitals and diagnostic centers, and others.
In 2016, the biotech and pharma segment estimated for the largest revenue share of over 47.0% due to rapid adoption of these systems for toxicity screening, drug discovery, and regenerative medicine development. These systems are preferred in drug discovery due to their efficient screening and target validation capabilities.
Based on component, the market can be classified into media and reagents and consumables.
The media segment occupies the major portion as compared to other segments due to high requirements for media, specifically in stem cell culture.
Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America estimated for the major market share of over 41.0%.
The U.S is the major contributor in this region due to presence of established pharma and biotech players work together with research laboratories to implement these technologies. Majority of healthcare expenditure is utilized on chronic diseases in the U.S, and Canada. This has resulted to rapid development of three-dimensional cell culture products by the major players in this region.
Asia Pacific is expected to witness the fastest growth over the forecast period due to developing infrastructure in this region, coupled with increasing awareness about upcoming technologies in healthcare amongst the population. Asia Pacific harbors 60.0% of the world population; thus, even a lower prevalence of chronic diseases translates into a large number of infected people, which is the leading factor driving segment growth. Furthermore, unmet needs of patients and untapped areas in this region have been attracting international market players and this is expected to boost revenue generation through to 2024.
Asia Pacific is expected to display significant growth during the forecast period due to robust developments in the field of tissue engineering and stem cell research. The region is anticipated to expand at a CAGR of 16% over the forecast period.
Prominent companies operating in the market include Global Cell Solutions, Inc.; Nano3D Biosciences Corning Inc.; 3D Biomatrix; Becton Dickinson and Company; and VWR International, LLC.
Major companies are emphasizing on to form alliances with laboratories for commercialization of technologies, which are not introduced to market.
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States